Fast-track drug brings prostate cancer hope as it could extend life expectancy for patients - Daily Mail

The NHS in England will become the first healthcare provider in Europe to roll out Darolutamide to patients whose prostate cancer has spread to other parts of the body.

The health service said it will begin to offer the drug to eligible prostate cancer patients within weeks.

NHS executive Amanda Pritchard said: 'It is fantastic that patients in England will be the first in Europe to receive this treatment for a really advanced and aggressive form of prostate cancer, thanks to the NHS fast tracking a new drug deal.'

Chiara De Biase, director of support and influencing at charity Prostate Cancer UK, said: 'Being told you have advanced prostate cancer can be devastating and we urgently need new treatments to help these men live longer

NHS national director for cancer Professor Peter Johnson said: 'We know that prostate cancer is the most common form of cancer among men and it is vital the NHS continues to diagnose patients as early as possible and expand our arsenal of cutting-edge treatments in order to increase the chances of people surviving

'This innovative treatment builds on the NHS ambition to improve cancer care and survival rates and will help thousands of men diagnosed with prostate cancer to live a better quality life, decreasing their chance of dying by one third.'